Nuformix (NFX)

Sector:

Pharma and Biotech

0.11p
   
  • Change Today:
      0.003p
  • 52 Week High: 0.22
  • 52 Week Low: 0.048
  • Currency: UK Pounds
  • Shares Issued: 1,995.71m
  • Volume: 12,812,969
  • Market Cap: £2.10m
  • RiskGrade: 322
  • Beta: 0.08

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio Not Available
Price Book Ratio
58.88% below the market average58.88% below the market average58.88% below the market average58.88% below the market average58.88% below the market average
10.53% below the sector average10.53% below the sector average10.53% below the sector average10.53% below the sector average10.53% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
89.17% below the market average89.17% below the market average89.17% below the market average89.17% below the market average89.17% below the market average
86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average86.96% below the sector average
Price Chg 3m
70.91% above the market average70.91% above the market average70.91% above the market average70.91% above the market average70.91% above the market average
78.26% above the sector average78.26% above the sector average78.26% above the sector average78.26% above the sector average78.26% above the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
43.69% below the market average43.69% below the market average43.69% below the market average43.69% below the market average43.69% below the market average
52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average52.38% below the sector average
Momentum 20
47.17% below the market average47.17% below the market average47.17% below the market average47.17% below the market average47.17% below the market average
28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average28.57% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin Not Available
ROCE
98.43% above the market average98.43% above the market average98.43% above the market average98.43% above the market average98.43% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
45.67% below the market average45.67% below the market average45.67% below the market average45.67% below the market average45.67% below the market average
24.44% above the sector average24.44% above the sector average24.44% above the sector average24.44% above the sector average24.44% above the sector average
Forecast EPS Not Available

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover Not Available
Operating Profit Loss
71.05% below the market average71.05% below the market average71.05% below the market average71.05% below the market average71.05% below the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
98.46% below the market average98.46% below the market average98.46% below the market average98.46% below the market average98.46% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Cash
96.23% below the market average96.23% below the market average96.23% below the market average96.23% below the market average96.23% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y Not Available
Buys 1y
53.1% below the market average53.1% below the market average53.1% below the market average53.1% below the market average53.1% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy Not Available
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Nuformix Market Data

Currency UK Pounds
Share Price 0.11p
Change Today 0.003p
% Change 2.44 %
52 Week High 0.22
52 Week Low 0.048
Volume 12,812,969
Shares Issued 1,995.71m
Market Cap £2.10m
Beta 0.08
RiskGrade 322

Nuformix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
36.26% below the market average36.26% below the market average36.26% below the market average36.26% below the market average36.26% below the market average
47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average47.83% above the sector average
Price Trend
27% below the market average27% below the market average27% below the market average27% below the market average27% below the market average
4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average4.35% above the sector average
Income Not Available
Growth Not Available

Nuformix Dividends

No dividends found

Trades for 06-Jun-2025

Time Volume / Share Price
16:26 1,848,308 @ 0.11p
16:16 250,000 @ 0.10p
16:14 250,000 @ 0.10p
15:25 225,431 @ 0.11p
15:12 11,899 @ 0.10p

Top of Page